Antiangiogenic therapy with bevacizumab in recurrent malignant gliomas: analysis of the response and core pathway aberrations

MLA

Wei, Zhang, et al. “Antiangiogenic Therapy with Bevacizumab in Recurrent Malignant Gliomas: Analysis of the Response and Core Pathway Aberrations.” Chinese Medical Journal, vol. 122, no. 11, July 2009. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........2fb8a4e2d18be70c8b4938da27d44d7e&authtype=sso&custid=ns315887.

APA

Wei, Z., Xiao-guang, Q., Bao-shi, C., Shou-wei, L., Yun, C., Huan, R., & Tao, J. (2009). Antiangiogenic therapy with bevacizumab in recurrent malignant gliomas: analysis of the response and core pathway aberrations. Chinese Medical Journal, 122(11).

Chicago

Wei, Zhang, Qiu Xiao-guang, Chen Bao-shi, Li Shou-wei, Cui Yun, Ren Huan, and Jiang Tao. 2009. “Antiangiogenic Therapy with Bevacizumab in Recurrent Malignant Gliomas: Analysis of the Response and Core Pathway Aberrations.” Chinese Medical Journal 122 (11). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........2fb8a4e2d18be70c8b4938da27d44d7e&authtype=sso&custid=ns315887.